- Table of Contents
- List of Tables
- List of Figures
- Global Aplastic Anemia Pipeline Overview
- Key Findings, 2019
- Disease Overview
- Report Guide and Research Methodology

- Executive Summary
- Aplastic Anemia Drugs under active development, H1- 2019
- Pipeline Drugs in Early Stage of Development (Pre-clinical, Discovery, Phase 1 and Phase 2)
- Pipeline Drugs in Advanced Stage of Development (Phase 3, Pre-registration)
- Companies involved in Aplastic Anemia pipeline, H1- 2019
- Mechanism of Action wise Aplastic Anemia Pipeline Candidates

- Acceleron Pharma Inc Aplastic Anemia Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Advanced Medical Projects Aplastic Anemia Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Amgen Inc Aplastic Anemia Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- BioLineRx Ltd Aplastic Anemia Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Cell Source Inc Aplastic Anemia Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Cellenkos Inc Aplastic Anemia Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Elixirgen Therapeutics LLC Aplastic Anemia Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- F. Hoffmann-La Roche Ltd Aplastic Anemia Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Gamida Cell Ltd Aplastic Anemia Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- HemoGenyx LLC Aplastic Anemia Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Jiangsu Hengrui Medicine Co Ltd Aplastic Anemia Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Regen BioPharma Inc Aplastic Anemia Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments
- Latest Aplastic Anemia Drug Pipeline Developments, 2019

- Appendix
- About Us
- Sources and Methodology
- Contact Information